72 related articles for article (PubMed ID: 155828)
21. Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties.
Korabecny J; Musilek K; Zemek F; Horova A; Holas O; Nepovimova E; Opletalova V; Hroudova J; Fisar Z; Jung YS; Kuca K
Bioorg Med Chem Lett; 2011 Nov; 21(21):6563-6. PubMed ID: 21920739
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of 1, 2, 3, 4-tetrahydro-9-amino-acridine.
Fusek J; Patocka J; Bajgar J; Bielavský J; Herink J; Hrdina V
Act Nerv Super (Praha); 1974 Aug; 16(3):226. PubMed ID: 4422035
[No Abstract] [Full Text] [Related]
23. Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons.
Zhou L; Liu YW; Peoples RW; Yang M; Tian X; Ai YX; Pang YP; Li ZW; Han YF; Li CY
Neuropharmacology; 2009 Jul; 57(1):33-40. PubMed ID: 19393253
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of huperzine B on cholinesterase activity in mice.
Liu J; Zhang HY; Wang LM; Tang XC
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161
[TBL] [Abstract][Full Text] [Related]
25. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
26. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC
Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444
[TBL] [Abstract][Full Text] [Related]
27. Continual determination of acetylcholinesterase inhibition following organophosphate poisoning using an auto analyzer.
Bajgar J; Fusek J; Patocka J; Hrdina V
Acta Biol Med Ger; 1977; 36(2):231-6. PubMed ID: 906734
[TBL] [Abstract][Full Text] [Related]
28. Effects of tacrine, aminopyridines, and physostigmine on acetylcholinesterase, acetylcholine release, and potassium currents.
Harvey AL; Rowan EG
Adv Neurol; 1990; 51():227-33. PubMed ID: 2294657
[No Abstract] [Full Text] [Related]
29. Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies.
Liu YW; Luo JL; Ren H; Peoples RW; Ai YX; Liu LJ; Pang YP; Li ZW; Han YF; Li CY
Neuropharmacology; 2008 Jun; 54(7):1086-94. PubMed ID: 18407299
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of 9-amino-7-methoxy-1,2,3,4-tetra-hydroacridine against inhibition of acetylcholinesterase by O-ethyl s-(2-dimethylaminoethyl) methylphosphonotioate in vivo.
Bajgar J; Fusek J; Patocka J; Hrdina V
Arch Toxicol; 1983 Oct; 54(2):163-6. PubMed ID: 6651529
[No Abstract] [Full Text] [Related]
31. Pharmacological study of 4-N-butylamino-1,2,3,4-tetrahydroacridine hydrochloride (Centbucridine)--a new local anaesthetic agent.
Patnaik GK; Dhawan BN
Indian J Exp Biol; 1982 Apr; 20(4):330-3. PubMed ID: 7183535
[No Abstract] [Full Text] [Related]
32. In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.
Thomsen T; Zendeh B; Fischer JP; Kewitz H
Biochem Pharmacol; 1991 Jan; 41(1):139-41. PubMed ID: 1986738
[No Abstract] [Full Text] [Related]
33. Changes of cholinesterases in the blood and some tissues following administration of tacrin and its two derivatives to rats.
Bajgar J; Fusek J; Skopec F
Neurochem Int; 1994 Jun; 24(6):555-8. PubMed ID: 7981637
[TBL] [Abstract][Full Text] [Related]
34. Preferential inhibition of acetylcholinesterase molecular forms in normal human brain.
Rakonczay Z; Török L; Kása P
Neurobiology (Bp); 1999; 7(1):75-7. PubMed ID: 10746253
[No Abstract] [Full Text] [Related]
35. Clinical pharmacology studies on 4-N-butylamino-1,2,3,4-tetrahydroacridine hydrochloride (Centbucridine)--a new local anaesthetic agent.
Gupta PP; Tangri AN; Saxena RC; Dhawan BN
Indian J Exp Biol; 1982 Apr; 20(4):344-6. PubMed ID: 7183539
[No Abstract] [Full Text] [Related]
36. Membrane-altering effects of velnacrine and N-methylacridinium: relevance to tacrine and Alzheimer's disease.
Butterfield DA; Rangachari A
Biochem Biophys Res Commun; 1992 Jun; 185(2):596-603. PubMed ID: 1319141
[TBL] [Abstract][Full Text] [Related]
37. A long-lasting cholinesterase inhibitor affecting neural and behavioral processes.
Brufani M; Castellano C; Marta M; Oliverio A; Pagella PG; Pavone F; Pomponi M; Rugarli PL
Pharmacol Biochem Behav; 1987 Mar; 26(3):625-9. PubMed ID: 3575379
[TBL] [Abstract][Full Text] [Related]
38. 9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase.
Nishibori M; Oishi R; Itoh Y; Saeki K
Jpn J Pharmacol; 1991 Apr; 55(4):539-46. PubMed ID: 1886293
[TBL] [Abstract][Full Text] [Related]
39. The interaction of ethanol with the cognitive enhancers tacrine, physostigmine, and AIT-082.
Ritzmann RF; Glasky A; Steinberg A; Melchior CL
J Gerontol; 1994 Mar; 49(2):B51-3. PubMed ID: 8126346
[TBL] [Abstract][Full Text] [Related]
40. In vitro inhibition of brain acetylcholinesterase by phosphamidon & physostigmine sulphate in adult chick.
Chattopadhyay R; Choudhuri DK; Maity CR
Indian J Med Res; 1986 Apr; 83():435-40. PubMed ID: 3721551
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
